TrialAlimentary pharmacology & therapeutics2022

Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.

Silvio Danese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.